輸入代號或公司名稱後按 Enter
6492

生華科

-0.30 (-0.88%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
33.60132成交張數本益比4.87股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.93-3.29-0.82-34357.1%-12.55%-39.03%
2026Q1-0.74-2.97-0.67-27864.2%-9.17%-32.49%
2025Q4-0.89-2.91-0.81-33724.2%-10.12%-29.62%
2025Q3-0.73-2.89-0.66-20099.7%-7.62%-27.16%
2025Q2-0.62-3.06-0.56-22453.2%-6.01%-26.64%
2025Q1-0.68-3.21-0.61-24547.6%-6.16%-26.27%
2024Q4-0.87-3.23-0.80-32052.0%-7.52%-25.06%
2024Q3-0.89-3.27-0.81-32324.0%-7.05%-23.69%
2024Q2-0.76-3.21-0.70-27862.4%-5.70%-21.89%
2024Q1-0.70-3.15-0.63-25259.6%-4.91%-20.48%
2023Q4-0.91-3.26-0.84-33436.8%-6.14%-20.22%
2023Q3-0.83-3.35-0.75-30056.4%-5.22%-19.57%
2023Q2-0.71-3.43-0.64-25768.0%-4.27%-19.12%
2023Q1-0.80-3.79-0.73-29261.2%-4.64%-20.18%
2022Q4-1.01-3.84-0.92-36730.8%-5.53%-19.52%
2022Q3-0.91-3.74-0.83-33034.0%-4.73%-17.93%
2022Q2-1.07-3.78-0.98-39037.6%-5.32%-17.42%
2022Q1-0.85-3.45-0.78-31050.4%-4.03%-15.33%
2021Q4-0.90-3.60-0.83-82538.0%-4.07%-15.33%
2021Q3-0.95-3.54-0.87-58104.0%-4.09%-14.57%
2021Q2-0.75-4.15-0.68-45478.0%-3.09%-25.12%
2021Q1-1.00-4.32-0.91-60897.3%-4.00%-24.29%
2020Q4-0.84-4.40-0.81-53928.7%-3.42%-22.50%
2020Q3-1.56-4.57-1.18-78658.7%-7.64%-21.26%
2020Q2-0.92-4.05-0.72-47932.0%-10.08%-37.93%
2020Q1-1.08-4.36-0.84-50358.7%-10.69%-37.25%
2019Q4-1.01-5.02-0.78-78343.0%-9.03%-38.41%
2019Q3-1.04-5.25-0.81-162828.0%-8.61%-37.16%
2019Q2-1.22-5.33-0.95-190396.0%-9.25%-35.14%
2019Q1-1.75-5.78-1.36-136471.0%-11.95%-34.92%
2018Q4-1.24-4.82-0.97-48530.0%-7.73%-27.06%
2018Q3-1.12-5.06-0.87-43584.0%-6.50%-26.42%
2018Q2-1.67-5.37-1.30-65090.5%-9.01%-26.25%
2018Q1-0.79-0.61-46196.2%-4.00%
2017Q4-1.48-1.15-7.07%
2017Q3-1.42-1.09-6.31%
2017Q2-0.91-0.69